Publication: Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection.
dc.contributor.author | Monforte, Víctor | |
dc.contributor.author | Sintes, Helena | |
dc.contributor.author | Ussetti, Piedad | |
dc.contributor.author | Castejón, Raquel | |
dc.contributor.author | Pérez, Virginia Luz | |
dc.contributor.author | Laporta, Rosalía | |
dc.contributor.author | Sole, Amparo | |
dc.contributor.author | Cifrián, José Manuel | |
dc.contributor.author | Marcos, Pedro J | |
dc.contributor.author | Redel, Javier | |
dc.contributor.author | Los Arcos, Ibai | |
dc.contributor.author | Sáez, Berta | |
dc.contributor.author | Alonso, Rodrigo | |
dc.contributor.author | Rosado, Silvia | |
dc.contributor.author | Escriva, Juan | |
dc.contributor.author | Iturbe, David | |
dc.contributor.author | Ovalle, Juan Pablo | |
dc.contributor.author | Vaquero, José Manuel | |
dc.contributor.author | Revilla, Eva | |
dc.contributor.author | Mendoza, Alberto | |
dc.contributor.author | Gómez-Ollés, Susana | |
dc.date.accessioned | 2023-05-03T14:45:16Z | |
dc.date.available | 2023-05-03T14:45:16Z | |
dc.date.issued | 2021-10-25 | |
dc.identifier.doi | 10.1016/j.arbres.2021.10.002 | |
dc.identifier.essn | 1579-2129 | |
dc.identifier.pmid | 35312499 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.arbres.2021.10.002 | |
dc.identifier.uri | http://hdl.handle.net/10668/22001 | |
dc.issue.number | 8 | |
dc.journal.title | Archivos de bronconeumologia | |
dc.journal.titleabbreviation | Arch Bronconeumol | |
dc.language.iso | en | |
dc.language.iso | es | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.page.number | 614-617 | |
dc.pubmedtype | Case Reports | |
dc.rights.accessRights | open access | |
dc.subject.mesh | Antiviral Agents | |
dc.subject.mesh | Cytomegalovirus Infections | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Kidney Transplantation | |
dc.subject.mesh | Lung | |
dc.subject.mesh | Transplant Recipients | |
dc.title | Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 58 | |
dspace.entity.type | Publication |